Kell and XK immunohistochemistry in McLeod myopathy

被引:41
作者
Jung, HH [1 ]
Russo, D
Redman, C
Brandner, S
机构
[1] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland
[2] New York Blood Ctr, New York, NY 10021 USA
[3] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
关键词
Kell protein; McLeod syndrome; myopathy; neuroacanthocytosis; XK protein;
D O I
10.1002/mus.1154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The McLeod syndrome is an X-linked neuroacanthocytosis manifesting with myopathy and progressive chorea. It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function. In erythroid tissues, XK forms a functional complex with the Kell glycoprotein. Here, we present an immunohistochemical study in skeletal muscle of normal controls and a McLeod patient with a XKgene point mutation (C977T) using affinity-purified antibodies against XK and Kell proteins. Histological examination of the affected muscle revealed the typical pattern of McLeod myopathy including type 2 fiber atrophy. In control muscles, Kell immunohistochemistry stained sarcoplasmic membranes. XK immunohistochemistry resulted in a type 2 fiber-specific intracellular staining that was most probably confined to the sarcoplasmic reticulum. In contrast, there was only a weak background signal without a specific staining pattern for XK and Kell in the McLeod muscle. Our results demonstrate that the lack of physiological XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and suggest that the XK protein represents a crucial factor for the maintenance of normal muscle structure and function. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:1346 / 1351
页数:6
相关论文
共 31 条
[21]   ELEVATED SERUM CREATINE-PHOSPHOKINASE IN SUBJECTS WITH MCLEOD-SYNDROME [J].
MARSH, WL ;
MARSH, NJ ;
MOORE, A ;
SYMMANS, WA ;
JOHNSON, CL ;
REDMAN, CM .
VOX SANGUINIS, 1981, 40 (06) :403-411
[22]  
MARSH WL, 1975, TRANSFUSION, V15, P527
[23]   Expression of Kell blood group protein in nonerythroid tissues [J].
Russo, D ;
Wu, X ;
Redman, CM ;
Lee, S .
BLOOD, 2000, 96 (01) :340-346
[24]   Intracellular assembly of Kell and XK blood group proteins [J].
Russo, D ;
Lee, S ;
Redman, C .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (01) :10-18
[25]   Association of XK and Kell blood group proteins [J].
Russo, D ;
Redman, C ;
Lee, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13950-13956
[26]   The ced-8 gene controls the timing of programmed cell deaths in C. elegans [J].
Stanfield, GM ;
Horvitz, HR .
MOLECULAR CELL, 2000, 5 (03) :423-433
[27]   BENIGN X-LINKED MYOPATHY WITH ACANTHOCYTES (MCLEOD SYNDROME) - ITS RELATIONSHIP TO X-LINKED MUSCULAR-DYSTROPHY [J].
SWASH, M ;
SCHWARTZ, MS ;
CARTER, ND ;
HEATH, R ;
LEAK, M ;
ROGERS, KL .
BRAIN, 1983, 106 (SEP) :717-733
[28]   Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX [J].
Turner, AJ ;
Tanzawa, K .
FASEB JOURNAL, 1997, 11 (05) :355-364
[29]   A novel mutation of the McLeod syndrome gene in a Japanese family [J].
Ueyama, H ;
Kumamoto, T ;
Nagao, S ;
Masuda, T ;
Sugihara, R ;
Fujimoto, S ;
Tsuda, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 176 (02) :151-154
[30]   HEMATOLOGICAL CHANGES ASSOCIATED WITH MCLEOD PHENOTYPE OF KELL BLOOD-GROUP SYSTEM [J].
WIMER, BM ;
MARSH, WL ;
TASWELL, HF ;
GALEY, WR .
BRITISH JOURNAL OF HAEMATOLOGY, 1977, 36 (02) :219-224